Search

everythinglearnresearchcommunity

for

Search:↓

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

The patient's scalp lesions stabilized with a combination of treatments after initial therapies failed.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Early and aggressive treatment with individualized care plans is crucial for managing pediatric systemic lupus erythematosus.

Careful management of blood thinners is crucial for lupus patients with APS.

Hair loss from conditions like LPP and FFA can potentially be reversed with the right treatment.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

The mRNA-1273 COVID-19 vaccine may worsen symptoms in people with systemic lupus erythematosus.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

GLPLS is a rare skin condition with specific hair loss and skin symptoms.

Sunscreen spray on the scalp may be linked to a type of scarring hair loss.

Nitrofurantoin may cause sub-acute cutaneous lupus erythematosus.

A woman with lupus had muscle weakness due to kidney issues and was successfully treated with medication.